James Basta
Overview
James Basta received $15M in total compensation, including $220K in salary, at Intellia Therapeutics in 2021. James Basta also received $2M at Kura Oncology in 2019.
Source: SEC filings on May 2, 2022 and April 28, 2020.
Related executives
We found 18 more executives who work or worked at Intellia Therapeutics and Kura Oncology.
John Leonard
Intellia Therapeutics
Chief Executive Officer
Laura Sepp-Lorenzino
Intellia Therapeutics
Chief Scientific Officer
David Lebwohl
Intellia Therapeutics
Chief Medical Officer
Glenn Goddard
Intellia Therapeutics
Chief Financial Officer
Troy Wilson
Kura Oncology
Chief Executive Officer
Stephen Dale
Kura Oncology
Chief Medical Officer
Kirsten Flowers
Kura Oncology
Chief Commercial Officer
Bridget MA
Kura Oncology